A recent study conducted at the University of Calgary and published in the Journal of Neuro-Oncology suggests that vitamin B3, also known as niacin, may play a promising role in supporting the immune system against one of the most aggressive brain tumors, glioblastoma, by enhancing immune cells’ ability to recognize and attack cancer cells more effectively.
According to SciTechDaily, this research reflects a growing scientific interest in the potential role of vitamins as complementary components in modern therapeutic strategies, especially for highly aggressive and treatment-resistant cancers.
Glioblastoma is considered one of the most dangerous forms of brain cancer due to its rapid growth and resistance to conventional treatments such as surgery, chemotherapy, and radiation therapy. Its severity is also linked to its ability to suppress the immune system, preventing the body from effectively identifying and attacking cancer cells.
Preliminary findings indicate that vitamin B3 may help reactivate certain immune components, particularly T-cells, enabling them to better target tumor cells and improve the overall immune response against the disease.
Early clinical data also suggest that incorporating niacin into a comprehensive treatment protocol may help slow disease progression in some patients, a result that researchers consider promising but still in need of further investigation.
Despite these encouraging findings, experts emphasize that this approach remains in the experimental stage. Therapeutic doses of vitamin B3 should only be taken under strict medical supervision due to potential side effects, particularly related to liver function at high doses.
Doctors also warn against unsupervised or excessive intake of vitamins, noting that natural dietary use differs significantly from controlled therapeutic applications, and misuse may lead to unintended consequences.
Overall, this study represents an important step toward understanding the role of the immune system in combating cancer and opens new avenues for therapies that focus on boosting the body’s natural defenses. However, further research and clinical trials are still required before this approach can be adopted as a standard medical treatment.
For more news and updates, follow Egypt Connect
